Why these 4 ASX shares have surged higher today

ResMed Inc. (CHESS) (ASX:RMD) is one of four shares which have had a particularly strong day on the market. Here's why their respective share prices have surged higher…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

After a disappointing start to the week the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has responded well and in afternoon trade is higher by 0.4% to 5,634 points.

Four shares which have done a lot of the heavy lifting are listed below. Here's why they have surged higher today:

BlueScope Steel Limited (ASX: BSL) shares have rocketed higher by 9% to $11.33 after the steel manufacturer released its preliminary half-year results. For the six months ended December 31 2017 BlueScope expects EBIT of $600 million. This not only smashes its previous guidance of $510 million, but equates to a 160% increase on the prior corresponding period.

Lynas Corporation Limited (ASX: LYC) shares have also surged 9% to 8.8 cents. Investors have been scrambling to get hold of the rare earth miner's shares after it released a positive quarterly update which revealed record production and sales, as well as significant cost savings. If rare earth prices recover then Lynas could be positioned perfectly to profit.

Mayne Pharma Group Ltd (ASX: MYX) shares have risen almost 3.5% to $1.29 despite there being no news out of the company. Whilst I think this growing pharmaceutical company is a bargain buy, its shares have been volatile in recent times due to price-fixing allegations and concerns over what impact a Trump presidency will have on the industry. This may make its shares unsuitable for those with a low tolerance for risk.

ResMed Inc. (CHESS) (ASX: RMD) shares have jumped 6% to $8.84 after the sleep treatment company posted another strong quarterly result. Thanks largely to a strong performance from its core U.S. business, ResMed delivered adjusted earnings per share of 73 U.S. cents. This was three cents ahead of the analyst consensus estimate. ResMed strikes me as a great buy and hold investment.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »